Skip to main content
. Author manuscript; available in PMC: 2023 Jun 25.
Published in final edited form as: Drug Alcohol Depend. 2020 Oct 2;216:108334. doi: 10.1016/j.drugalcdep.2020.108334

Table 3.

Multivariate analysis across all subjects (N = 418): factors associated with major depressive episode and psychotic disorder

Unadjusted prevalence Ratio Prevalence Ratio 95% CI
Major depressive episode
Daily heroin use (in the past month) 0.68 0.52 0.34 – 0.83
Duration heroin use** 1.16 1.15 0.97 – 1.38
Current methadone treatment 0.71 0.64 0.40 – 0.98
Regular poly-substance use (ref = 0)*
One substance 0.91 1.27 0.73 – 2.30
Two substances 0.82 1.23 0.61 – 2.47
Three substances 1.81 2.72 1.09 – 6.23
Current psychotic disorder
Daily heroin use (in the past month) 0.57 0.3 0.18 – 0.52
Duration heroin use** 1.22 1.17 0.95 – 1.47
Current methadone treatment 0.74 0.68 0.39 – 1.11
Regular poly-substance use (ref = 0)*
One substance 0.94 1.82 0.92 – 3.97
Two substances 1.15 2.77 1.21 – 6.50
Three substances 3.45 9.35 3.50 – 24.94
*

Regular poly-substance use. including daily heroin injection. regular methamphetamine use (≥ 4 times in the last 30 days). and alcohol misuse

**

Levels were set as follows: less than 5 years (ref); 5–10 years; 10–15 years; 15+ years. Coefficient for each level increase